keyword
https://read.qxmd.com/read/38652928/risk-factors-of-in-hospital-mortality-and-discriminating-capacity-of-nivo-score-in-exacerbations-of-copd-requiring-noninvasive-ventilation
#1
JOURNAL ARTICLE
Jiarui Zhang, Qun Yi, Chen Zhou, Yuanming Luo, Hailong Wei, Huiqing Ge, Huiguo Liu, Jianchu Zhang, Xianhua Li, Xiufang Xie, Pinhua Pan, Mengqiu Yi, Lina Cheng, Hui Zhou, Liang Liu, Adila Aili, Yu Liu, Lige Peng, Jiaqi Pu, Haixia Zhou
BACKGROUND: Noninvasive mechanical ventilation (NIV) is recommended as the initial mode of ventilation to treat acute respiratory failure in patients with AECOPD. The Noninvasive Ventilation Outcomes (NIVO) score has been proposed to evaluate the prognosis in patients with AECOPD requiring assisted NIV. However, it is not validated in Chinese patients. METHODS: We used data from the MAGNET AECOPD Registry study, which is a prospective, noninterventional, multicenter, real-world study conducted between September 2017 and July 2021 in China...
2024: Chronic Respiratory Disease
https://read.qxmd.com/read/38652526/leveraging-ai-and-machine-learning-to-develop-and-evaluate-a-contextualized-user-friendly-cough-audio-classifier-for-detecting-respiratory-diseases-protocol-for-a-diagnostic-study-in-rural-tanzania
#2
JOURNAL ARTICLE
Kahabi Ganka Isangula, Rogers John Haule
BACKGROUND: Respiratory diseases, including active tuberculosis (TB), asthma, and chronic obstructive pulmonary disease (COPD), constitute substantial global health challenges, necessitating timely and accurate diagnosis for effective treatment and management. OBJECTIVE: This research seeks to develop and evaluate a noninvasive user-friendly artificial intelligence (AI)-powered cough audio classifier for detecting these respiratory conditions in rural Tanzania. METHODS: This is a nonexperimental cross-sectional research with the primary objective of collection and analysis of cough sounds from patients with active TB, asthma, and COPD in outpatient clinics to generate and evaluate a noninvasive cough audio classifier...
April 23, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38652339/identification-and-experimental-validation-of-pycard-as-a-crucial-panoptosis-related-gene-for-immune-response-and-inflammation-in-copd
#3
JOURNAL ARTICLE
Rui Shi, Renwen Liang, Fang Wang, Lueli Wang, Wuyi Zidai, Jie Zhang, Luo Min, Xiaohua Du, Shibo Sun, Chuang Xiao, Chaozhong Li, Xuewu Liang, Alex F Chen, Weimin Yang
Chronic inflammatory and immune responses play key roles in the development and progression of chronic obstructive pulmonary disease (COPD). PANoptosis, as a unique inflammatory cell death modality, is involved in the pathogenesis of many inflammatory diseases. We aim to identify critical PANoptosis-related biomarkers and explore their potential effects on respiratory tract diseases and immune infiltration landscapes in COPD. Total microarray data consisting of peripheral blood and lung tissue datasets associated with COPD were obtained from the GEO database...
April 23, 2024: Apoptosis: An International Journal on Programmed Cell Death
https://read.qxmd.com/read/38652281/examining-the-contribution-of-notch-signaling-to-lung-disease-development
#4
REVIEW
Samar A Antar, Mohamed Kh ElMahdy, Ahmed G Darwish
Notch pathway is a widely observed signaling system that holds pivotal functions in regulating various developmental cellular functions and operations. The Notch signaling mechanism is crucial for lung homeostasis, damage, and restoration. Based on increasing evidence, the Notch pathway has been identified, as critical for fibrosis and subsequently, the development of chronic fibroproliferative conditions in various organs and tissues. Recent research indicates that deregulation of Notch signaling correlates with the pathogenesis of significant pulmonary conditions, particularly chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, asthma, pulmonary arterial hypertension (PAH), lung carcinoma, and pulmonary abnormalities in some hereditary disorders...
April 23, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38652265/umeclidinium-plus-vilanterol-versus-fluticasone-propionate-plus-salmeterol-for-chronic-obstructive-pulmonary-disease-a-meta-analysis-of-randomized-controlled-trials
#5
JOURNAL ARTICLE
Chunjuan Zhai, Fen Wang, Ruie Xu, Xia Sun, Wenbin Ma, Li Wang
PURPOSE: Umeclidinium plus vilanterol (UMEC/VI) is an inhaled long-acting muscarinic antagonist/long-acting beta2-agonist (LAMA/LABA), recently approved as once-daily maintenance therapy for chronic obstructive pulmonary disease (COPD). This meta-analysis aims to assess the efficacy and safety of UMEC/VI compared with fluticasone propionate plus salmeterol (FP/SAL). METHODS: A systematic search was conducted by a trained medical research librarian across MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Chinese Biomedical Literature Database (CBM) for randomized controlled trials comparing UMEC/VI with FP/SAL in COPD patients...
April 23, 2024: Postgraduate Medical Journal
https://read.qxmd.com/read/38651412/analysis-of-endocrine-and-inflammatory-markers-in-preserved-ratio-impaired-spirometry
#6
JOURNAL ARTICLE
Fabíola Ramos Jesus, Anna Clara Santiago Moraes, Ingrid Lorena Neves da Silva, Fabine Correia Passos, Cristina Salles, Margarida Célia Lima Costa Neves, Gyselle Chrystina Baccan
Chronic Obstructive Pulmonary Disease (COPD) is a disease of the lungs characterized by chronic airflow obstruction. Individuals with preserved ratio impaired spirometry (PRISm) may be at risk for developing COPD. This study aimed to characterize PRISm and COPD patients in terms of their immune response and endocrine profile to identify differences extending beyond lung function. The participants performed the clinical assessment, pulmonary function test, and blood collection to determine serum hormone levels and concentrations of cytokine...
March 27, 2024: Medical Sciences: Open Access Journal
https://read.qxmd.com/read/38651366/pathogenesis-of-pm-2-5-related-disorders-in-different-age-groups-children-adults-and-the-elderly
#7
REVIEW
Teerachai Amnuaylojaroen, Nichapa Parasin
The effects of PM2.5 on human health fluctuate greatly among various age groups, influenced by a range of physiological and immunological reactions. This paper compares the pathogenesis of the disease caused by PM2.5 in people of different ages, focusing on how children, adults, and the elderly are each susceptible to it because of differences in their bodies. Regarding children, exposure to PM2.5 is linked to many negative consequences. These factors consist of inflammation, oxidative stress, and respiratory problems, which might worsen pre-existing conditions and potentially cause neurotoxicity and developmental issues...
March 31, 2024: Epigenomes
https://read.qxmd.com/read/38651092/development-of-a-performance-based-toolkit-of-the-treatable-traits-of-functioning-in-hospitalised-patients-with-exacerbation-of-copd-a-survey-based-study-protocol
#8
JOURNAL ARTICLE
Naiara Tais Leonardi, Débora Mayumi Oliveira Kawakami, Joana Cruz, Chris Burtin, Audrey Borghi-Silva, Renata Gonçalves Mendes
BACKGROUND: The management of COPD has been based on the premise of identifying problems that guide personalised treatment based on a multidimensional assessment, known as treatable traits. Exacerbation of COPD (ECOPD) results in physical and functional impairments, limitation of daily activities and negative impact on patients' quality of life and prognosis. In this context, identifying treatable traits in patients with ECOPD is essential to properly guide individualised patient care...
March 2024: ERJ Open Research
https://read.qxmd.com/read/38650913/do-causes-influence-functional-aspects-and-quality-of-life-in-patients-with-nonfibrocystic-bronchiectasis
#9
JOURNAL ARTICLE
Ádria Cristina da Silva, Jessica de Campos Medeiros, Monica Corso Pereira
BACKGROUND: The denomination of noncystic fibrosis bronchiectasis (NCFB) includes several causes, and differences may be expected between the patient subgroups regarding age, comorbidities, and clinical and functional evolution. This study sought to identify the main causes of NCFB in a cohort of stable adult patients and to investigate whether such conditions would be different in their clinical, functional, and quality of life aspects. METHODS: Between 2017 and 2019, all active patients with NCFB were prospectively evaluated searching for clinical data, past medical history, dyspnea severity grading, quality of life data, microbiological profile, and lung function (spirometry and six-minute walk test)...
2024: Pulmonary Medicine
https://read.qxmd.com/read/38650847/capn5-attenuates-cigarette-smoke-extract-induced-apoptosis-and-inflammation-in-beas-2b-cells
#10
JOURNAL ARTICLE
Herui Li, Yiming Ma, Tiao Li, Zihang Zeng, Lijuan Luo, Xiangming Liu, Yi Li, Yan Chen
INTRODUCTION: Apoptosis and chronic inflammation are the main phenotypes in chronic obstructive pulmonary disease (COPD) pathogenesis. Cigarette smoke exposure is the leading risk factor for COPD, which causes aberrant airway epithelial structure and function. As a non-classical calpain, the molecular function of calpain5 (CAPN5) in COPD remains unclear. This study investigated the role of CAPN5 in mediating cigarette smoke extract (CSE)-induced apoptosis and inflammation. METHODS: Immunohistochemistry (IHC) and Western blotting (WB) were performed to detect the location and expression of CAPN5...
2024: Tobacco Induced Diseases
https://read.qxmd.com/read/38650680/therapeutic-effects-of-lifei-decoction-in-a-murine-model-of-copd-induced-by-lps-and-cigarette-smoke
#11
JOURNAL ARTICLE
Liguo Lu, Chengdong Zhu, Jian Xu, Yulan Hu, Juxiang Dai, Sheng Wang, Tao Wei
INTRODUCTION: The Lifei Decoction (LD) is a commonly utilized Chinese medicine for the treatment of sepsis and bronchial inflammation. However, its therapeutic potential in chronic obstructive pulmonary disease (COPD) remains unknown. Therefore, the objective of this study was to investigate the therapeutic efficacy and underlying mechanism of LD in a mouse model of COPD induced by cigarette smoke (CS) combined with lipopolysaccharide (LPS). METHODS: Hematoxylin-eosin (H&E) staining was employed to observe the pathological alterations in lung tissue, while ELISA was utilized for the detection of levels of inflammatory factors in both lung tissue and bronchoalveolar lavage fluid (BALF)...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38649963/associations-between-outpatient-care-and-later-hospital-admissions-for-patients-with-chronic-obstructive-pulmonary-disease-a-registry-study-from-norway
#12
JOURNAL ARTICLE
Tron Anders Moger, Jon Helgheim Holte, Olav Amundsen, Silje Bjørnsen Haavaag, Anne Edvardsen, Line Kildal Bragstad, Ragnhild Hellesø, Trond Tjerbo, Nina Køpke Vøllestad
BACKGROUND: Although chronic obstructive pulmonary disease (COPD) admissions put a substantial burden on hospitals, most of the patients' contacts with health services are in outpatient care. Traditionally, outpatient care has been difficult to capture in population-based samples. In this study we describe outpatient service use in COPD patients and assess associations between outpatient care (contact frequency and specific factors) and next-year COPD hospital admissions or 90-day readmissions...
April 22, 2024: BMC Health Services Research
https://read.qxmd.com/read/38649893/effects-and-long-term-outcomes-of-endurance-versus-resistance-training-as-an-adjunct-to-standard-medication-in-patients-with-stable-copd-a-multicenter-randomized-trial
#13
JOURNAL ARTICLE
Shilei Cui, Haiying Ji, Li Li, Huili Zhu, Xiangyang Li, Ying Gong, Yuanlin Song, Lijuan Hu, Xu Wu
BACKGROUND: Comparisons between endurance training (ET) and resistance training (RT) have produced equivocal findings in chronic obstructive pulmonary disease (COPD) patients. The purpose of our study is to investigate the effectiveness and long-term outcomes of adding ET and RT to conventional medical treatment in patients with COPD. A secondary objective is to investigate the clinical improvements resulting from exercise training in patients with different disease severities. METHODS: The study was a multicenter, prospective trial in people with stable COPD...
April 22, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38649783/differentially-co-expressed-myofibre-transcripts-associated-with-abnormal-myofibre-proportion-in-chronic-obstructive-pulmonary-disease
#14
JOURNAL ARTICLE
Joe W Chiles, Ava C Wilson, Rachel Tindal, Kaleen Lavin, Samuel Windham, Harry B Rossiter, Richard Casaburi, Anna Thalacker-Mercer, Thomas W Buford, Rakesh Patel, J Michael Wells, Marcas M Bamman, Beatriz Y Hanaoka, Mark Dransfield, Merry-Lynn N McDonald
BACKGROUND: Skeletal muscle dysfunction is a common extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD). Alterations in skeletal muscle myosin heavy chain expression, with reduced type I and increased type II myosin heavy chain expression, are associated with COPD severity when studied in largely male cohorts. The objectives of this study were (1) to define an abnormal myofibre proportion phenotype in both males and females with COPD and (2) to identify transcripts and transcriptional networks associated with abnormal myofibre proportion in COPD...
April 22, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38649275/a-step-forward-to-help-patients-with-copd-to-perform-ambulatory-exercises
#15
EDITORIAL
Jean-Luc Diehl, Emmanuelle Guérin, Emmanuel Guérot
No abstract text is available yet for this article.
April 22, 2024: Respiratory Care
https://read.qxmd.com/read/38649272/in-person-versus-remote-6-minute-walk-and-incremental-shuttle-walk-distances-in-advanced-lung-disease
#16
JOURNAL ARTICLE
Lisa M Wickerson, Manoela de Paula Ferreira, Dmitry Rozenberg, Sunita Mathur, Lianne G Singer
BACKGROUND: Field-based walk tests conducted remotely may provide an alternative method to a facility-based assessment of exercise capacity for people with advanced lung disease. This prospective study evaluated the level of agreement in the distance walked between a 6-min walk test (6MWT) and an incremental shuttle walk test performed by using standard in-person procedures and test variations and settings. METHODS: Adults with advanced lung disease underwent 4 study visits: (i) one in-person standard 6MWT (30-m corridor) and one in-person treadmill 6MWT, (ii) a remote 6MWT in a home setting (10-m corridor), (iii) 2 in-person standard incremental shuttle walk tests (10-m corridor), and (iv) a remote incremental shuttle walk test in a home setting (10-m corridor)...
April 22, 2024: Respiratory Care
https://read.qxmd.com/read/38646606/characteristics-of-users-and-new-initiators-of-single-and-multiple-inhaler-triple-therapy-for-chronic-obstructive-pulmonary-disease-in-germany
#17
JOURNAL ARTICLE
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fränce Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
PURPOSE: To assess patient characteristics of users and new initiators of triple therapy for chronic obstructive pulmonary disease (COPD) in Germany. PATIENTS AND METHODS: Retrospective cohort study of patients with COPD and ≥1 prescription for single-inhaler triple therapy (SITT; fluticasone furoate/umeclidinium/vilanterol [FF/UMEC/VI] or beclomethasone dipropionate/glycopyrronium bromide/formoterol [BDP/GLY/FOR]) or multiple-inhaler triple therapy (MITT), using data from the AOK PLUS German sickness fund (1 January 2015-31 December 2019)...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38646605/neutrophil-to-lymphocyte-ratio-nlr-platelet-to-lymphocyte-ratio-plr-and-monocyte-to-lymphocyte-ratio-mlr-as-biomarkers-in-diagnosis-evaluation-of-acute-exacerbation-of-chronic-obstructive-pulmonary-disease-a-retrospective-observational-study
#18
JOURNAL ARTICLE
Chuang Cai, Wentan Zeng, Hongwei Wang, Shuqi Ren
PURPOSE: Hierarchical management is advocated in China to effectively manage chronic obstructive pulmonary disease (COPD) patients and reduce the incidence and mortality of acute exacerbation of COPD (AE-COPD). However, primary and community hospitals often have limited access to advanced equipment and technology. Complete blood count (CBC), which is commonly used in these hospitals, offers the advantages of being cost-effective and easily accessible. This study aims to evaluate the significance of routine blood indicators in aiding of diagnosing AE-COPD...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38646561/risk-factors-for-anxiety-and-its-impacts-on-acute-exacerbation-in-older-patients-with-chronic-obstructive-pulmonary-disease
#19
JOURNAL ARTICLE
Yan Mou, Lin Shan, Yunhuan Liu, Yue Wang, Zhengming He, Xiangyang Li, Huili Zhu, Haiyan Ge
BACKGROUND: Anxiety is common in patients with chronic obstructive pulmonary disease (COPD), especially in older patients with the definition of age over 60 years old. Few studies have focused on anxiety in older COPD patients. This study aimed to analyze the risk factors of anxiety in older COPD patients and the impacts of anxiety on future acute exacerbation. METHODS: The general information, questionnaire data, previous acute exacerbation and pulmonary function were collected...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38646255/sarcopenia-eosinophil-to-platelet-ratio-and-c-reactive-protein-as-predictors-of-adverse-events-in-patients-with-acute-exacerbations-of-chronic-obstructive-pulmonary-disease-a-prospective-observational-study
#20
JOURNAL ARTICLE
Rohankumar Gandhi, Vijay Kalsariya, Roshan Katara, Yogesh Murugan
BACKGROUND: Biomarkers such as sarcopenia, eosinopenia, and C-reactive protein (CRP) may predict adverse events in chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to determine their prognostic utility and accuracy versus conventional measures. METHODS: This was a prospective analysis of COPD patients hospitalized for acute exacerbations for more than one year. Patients with primary diagnoses other than COPD were excluded. A total of 200 participants were screened, and 50 experienced adverse events, including mortality, rehospitalization, prolonged stay, hypoxemia, or hypercapnia...
March 2024: Curēus
keyword
keyword
827
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.